Reply to 'It May be Time to Abandon Urine Tests for Bladder Cancer'
J Natl Compr Canc Netw
.
2017 May;15(5):lxx-lxxii.
doi: 10.6004/jnccn.2017.0054.
Authors
Hideki Furuya
1
,
Charles J Rosser
1
,
Brant A Inman
2
,
Joseph J Fantony
2
Affiliations
1
University of Hawaii Cancer Center, Clinical and Translational Research Program.
2
Duke Cancer Institute, Durham, North Carolina.
PMID:
28476745
DOI:
10.6004/jnccn.2017.0054
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers, Tumor
Humans
Sensitivity and Specificity
Urinary Bladder Neoplasms*
Substances
Biomarkers, Tumor